Open-house discount agreements for medicines containing brinzolamide and brimonidine

Summary

The procurement concerns non-exclusive discount agreements for medicines containing the active ingredients brinzolamide and brimonidine, covering the period from 1 December 2026 to 30 November 2028. Under the open-house model, agreements may be concluded at any time during that period. Medicines included on the BfArM list of paediatric medicines are excluded.